Profile
Mr. Ralph was a Corporate Advisor principally in the biotechnology sector.
He holds a Degree in Pure and Applied Mathematics (University of Sydney), is Managing Director of The New Millennium Fund (Pooled Development Fund specialising in biotech).
He has 26 years of experience in the financial markets.
Mr Ralph has an established track record in taking scientific inventions from inception to the financial markets.
He has been a director (including roles as chairman and MD) of several public companies.
Former positions of Paul Ralph
| Companies | Position | End |
|---|---|---|
| MEDIVAC LTD | Director/Board Member | 29/11/2007 |
| Colorado Investments Pty Ltd. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Colorado Investments Pty Ltd. | Finance |
Growth Capital Group Ltd.
 Growth Capital Group Ltd. Electronic Equipment/InstrumentsElectronic Technology MediVac Ltd. engages in the developing and commercializing on-site, clinical waste conversion technology. It products include SunnyWipes, which consists of various antimicrobial hand hygiene and general cleaning products and Diakyne that identifies trace elements in body fluids using the Tracesmart technology. The company was founded on April 13, 1992 and is headquartered in Sydney, Australia. | Electronic Technology |
- Stock Market
- Insiders
- Paul Ralph